{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T10:16:38Z","timestamp":1787912198750,"version":"build-2784847793"},"reference-count":47,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2025,9,7]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Red blood cell (RBC) transfusions are commonly used to manage anemia-related symptoms, such as fatigue and dyspnea in patients with advanced cancer. Their use in palliative care (PC) remains controversial due to the lack of clear guidelines, potential risks, and ethical considerations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This narrative review aims to evaluate the role of RBC transfusions in patients with advanced cancer and those at the end of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and data sources<\/jats:title>\n                    <jats:p>A comprehensive review of relevant existing literature was performed in various databases, using combinations of relevant keywords. Only studies published in English were considered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>Anemia affects up to 77% of men and 68% of women with advanced cancer in palliative care. RBC transfusions may offer temporary symptomatic relief, but evidence supporting their routine use in palliative cancer patients is inconclusive. Studies report subjective response rates ranging from 31% to 70%. Benefits on fatigue and dyspnea often last &lt;2 weeks and 23\u201335% of patients die within two weeks after the transfusion, raising concerns about futility. Variability in transfusion practices across different palliative care settings highlights the influence of clinician attitudes, resource availability, and institutional policies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>RBC transfusions in advanced cancer and end-of-life care should be considered on a case-by-case basis, prioritizing patient-centered decision-making and ethical considerations. Though the benefit is often short, they may improve the quality of life for highly selected patients. Risks such as adverse reactions and resource allocation concerns must be considered. Further research is needed to establish evidence-based guidelines and standardized assessment tools to evaluate transfusion efficacy in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/spcare-2025-005579","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T06:15:19Z","timestamp":1759472119000},"page":"1073-1080","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Red blood cell transfusions in advanced cancer near the end-of-life: narrative review"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1527-2118","authenticated-orcid":false,"given":"Daniele","family":"Marelli","sequence":"first","affiliation":[{"name":"Dipartimento di Specialit\u00e0 Medico-Chirurgiche, Scienze Radiologiche e Sanit\u00e0 Pubblica, Universit\u00e0 degli Studi di Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Romelli","sequence":"additional","affiliation":[{"name":"Dipartimento di Specialit\u00e0 Medico-Chirurgiche, Scienze Radiologiche e Sanit\u00e0 Pubblica, Universit\u00e0 degli Studi di Brescia, Brescia, Italy"},{"name":"ASST Spedali Civili di Brescia, Brescia, Lombardy, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cornali","sequence":"additional","affiliation":[{"name":"ASST Spedali Civili di Brescia, Brescia, Lombardy, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Martinelli","sequence":"additional","affiliation":[{"name":"ASST Spedali Civili di Brescia, Brescia, Lombardy, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sbrana","sequence":"additional","affiliation":[{"name":"Azienda Ospedaliero Universitaria Pisana, Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5156-8638","authenticated-orcid":false,"given":"Cosimo","family":"Chelazzi","sequence":"additional","affiliation":[{"name":"Dipartimento di Specialit\u00e0 Medico-Chirurgiche, Scienze Radiologiche e Sanit\u00e0 Pubblica, Universit\u00e0 degli Studi di Brescia, Brescia, Italy"},{"name":"ASST Spedali Civili di Brescia, Brescia, Lombardy, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"2026082802200682000_16.5.1073.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2003.04.001"},{"key":"2026082802200682000_16.5.1073.2","doi-asserted-by":"publisher","DOI":"10.1159\/000083128"},{"key":"2026082802200682000_16.5.1073.3","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2006.0199"},{"key":"2026082802200682000_16.5.1073.4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.12968\/ijpn.2016.22.5.244","article-title":"Cancer-related fatigue in palliative care: a global perspective","volume":"22","author":"Vilchynska","year":"2016","journal-title":"Int J Palliat Nurs"},{"key":"2026082802200682000_16.5.1073.5","doi-asserted-by":"crossref","unstructured":"Preston NJ , Hurlow A , Brine J , et al . Blood transfusions for anaemia in patients with advanced cancer. Cochrane Database Syst Rev 2016;2016. doi:10.1002\/14651858.CD009007.pub2","DOI":"10.1002\/14651858.CD009007.pub2"},{"key":"2026082802200682000_16.5.1073.6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.annonc.2020.02.016","article-title":"Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment","volume":"31","author":"Fabi","year":"2020","journal-title":"Ann Oncol"},{"key":"2026082802200682000_16.5.1073.7","doi-asserted-by":"crossref","first-page":"iv96","DOI":"10.1093\/annonc\/mdx758","article-title":"Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines","volume":"29","author":"Aapro","year":"2018","journal-title":"Ann Oncol"},{"key":"2026082802200682000_16.5.1073.8","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-001038","article-title":"Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines","volume":"5","author":"Hui","year":"2020","journal-title":"ESMO Open"},{"key":"2026082802200682000_16.5.1073.9","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.20.03465","article-title":"Management of Dyspnea in Advanced Cancer: ASCO Guideline","volume":"39","author":"Hui","year":"2021","journal-title":"JCO"},{"key":"2026082802200682000_16.5.1073.10","doi-asserted-by":"crossref","first-page":"v169","DOI":"10.1093\/annonc\/mdv306","article-title":"Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines","volume":"26 Suppl 5","author":"Kloke","year":"2015","journal-title":"Ann Oncol"},{"key":"2026082802200682000_16.5.1073.11","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2015.0122"},{"key":"2026082802200682000_16.5.1073.12","unstructured":"Scottish palliative care guidelines. Right decisions \u2014 rightdecisions.scot.nhs.uk. Available: https:\/\/rightdecisions.scot.nhs.uk\/scottish-palliative-care-guidelines [Accessed 18 Mar 2025]."},{"key":"2026082802200682000_16.5.1073.13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/09699260.2017.1328774","article-title":"Do blood transfusions make a difference when you are dying?","volume":"25","author":"Woodwark","year":"2017","journal-title":"Prog Palliat Care"},{"key":"2026082802200682000_16.5.1073.14","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1089\/jpm.2024.0153","article-title":"Red Blood Cell Transfusions in Patients with Advanced Cancer Receiving Home Palliative Care","volume":"27","author":"Ostan","year":"2024","journal-title":"J Palliat Med"},{"key":"2026082802200682000_16.5.1073.15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1089\/jpm.2010.0143","article-title":"Assessment of fatigue after blood transfusion in palliative care patients: a feasibility study","volume":"13","author":"Brown","year":"2010","journal-title":"J Palliat Med"},{"key":"2026082802200682000_16.5.1073.16","doi-asserted-by":"crossref","DOI":"10.1097\/j.pbj.0000000000000195","article-title":"Transfusion practices in patients with advanced cancer: a retrospective study in a palliative care service","volume":"7","author":"Marote","year":"2022","journal-title":"Porto Biomed J"},{"key":"2026082802200682000_16.5.1073.17","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1089\/jpm.2016.0073","article-title":"Can We Detect Transfusion Benefits in Palliative Care Patients?","volume":"19","author":"To","year":"2016","journal-title":"J Palliat Med"},{"key":"2026082802200682000_16.5.1073.18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12904-019-0454-1","article-title":"Does packed red cell transfusion provide symptomatic benefits to cancer palliative patients?: a longitudinal study from a single private oncology center in Nepal","volume":"18","author":"Timilsina","year":"2019","journal-title":"BMC Palliat Care"},{"key":"2026082802200682000_16.5.1073.19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1089\/jpm.2013.0387","article-title":"Transfusion in Palliative Cancer Patients: A Review of the Literature","volume":"17","author":"Torres","year":"2014","journal-title":"J Palliat Med"},{"key":"2026082802200682000_16.5.1073.20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.7326\/0003-4819-126-2-199701150-00013","article-title":"The care of dying patients","volume":"126","author":"Feinberg","year":"1997","journal-title":"Ann Intern Med"},{"key":"2026082802200682000_16.5.1073.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607183350311"},{"key":"2026082802200682000_16.5.1073.22","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-019-0832-0","article-title":"Transfusion as a Palliative Strategy","volume":"21","author":"Raval","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"2026082802200682000_16.5.1073.23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2018-001494"},{"key":"2026082802200682000_16.5.1073.24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.coc.0000136021.27983.29","article-title":"Medical Staff Attitudes: Views and Positions Regarding Blood Transfusion to Terminally Ill Cancer Patients","volume":"27","author":"Leibovitz","year":"2004","journal-title":"Am J Clin Oncol"},{"key":"2026082802200682000_16.5.1073.25","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7547-11-16"},{"key":"2026082802200682000_16.5.1073.26","doi-asserted-by":"publisher","DOI":"10.3310\/hta20220"},{"key":"2026082802200682000_16.5.1073.27","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2008.0139"},{"key":"2026082802200682000_16.5.1073.28","doi-asserted-by":"publisher","DOI":"10.1016\/0885-3924(96)00044-9"},{"key":"2026082802200682000_16.5.1073.29","doi-asserted-by":"publisher","DOI":"10.1177\/026921639500900405"},{"key":"2026082802200682000_16.5.1073.30","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyac184"},{"key":"2026082802200682000_16.5.1073.31","doi-asserted-by":"crossref","DOI":"10.1016\/S0885-3924(97)00058-4","article-title":"Blood transfusions in patients with advanced cancer","volume":"13","author":"Davies","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"2026082802200682000_16.5.1073.32","unstructured":"Overview | Blood transfusion | Guidance. NICE. Available: https:\/\/www.nice.org.uk\/guidance\/ng24 [Accessed 18 Dec 2024]."},{"key":"2026082802200682000_16.5.1073.33","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1592\/phco.22.16.1433.33690","article-title":"Validity of cancer-related fatigue instruments","volume":"22","author":"Schwartz","year":"2002","journal-title":"Pharmacotherapy"},{"key":"2026082802200682000_16.5.1073.34","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1089\/jpm.2017.0072","article-title":"The Prospective Evaluation of the Net Effect of Red Blood Cell Transfusions in Routine Provision of Palliative Care","volume":"20","author":"To","year":"2017","journal-title":"J Palliat Med"},{"key":"2026082802200682000_16.5.1073.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(96)00274-6"},{"key":"2026082802200682000_16.5.1073.36","doi-asserted-by":"crossref","unstructured":"Harvey AR , Basavaraju SV , Chung K , et al . Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States. Transfusion 2010;709\u201318. doi:10.1111\/trf.12918","DOI":"10.1111\/trf.12918"},{"key":"2026082802200682000_16.5.1073.37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpainsymman.2023.09.024","article-title":"Perspectives on Transfusions for Hospice Patients With Blood Cancers: A Survey of Hospice Providers","volume":"67","author":"Knight","year":"2024","journal-title":"J Pain Symptom Manage"},{"key":"2026082802200682000_16.5.1073.38","unstructured":"American society of hematology. In: ASH statement in support of palliative blood transfusions in hospice setting. Available: https:\/\/www.hematology.org\/advocacy\/policy-statements\/2019\/palliative-blood-transfusions-in-hospice"},{"key":"2026082802200682000_16.5.1073.39","unstructured":"Sen . S.2566 - 117th congress (2021-2022): improving access to transfusion care for hospice patients act of 2021. Congress.gov; 2021. Available: www.congress.gov\/bill\/117th-congress\/senate-bill\/2566 [Accessed 2 Jun 2025]."},{"key":"2026082802200682000_16.5.1073.40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tmrv.2022.06.003","article-title":"Home Delivery: Transfusion Services When and Where They Are Needed","volume":"36","author":"Shaw","year":"2022","journal-title":"Transfus Med Rev"},{"key":"2026082802200682000_16.5.1073.41","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-842575"},{"key":"2026082802200682000_16.5.1073.42","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.30735","article-title":"Why are patients with blood cancers more likely to die without hospice?","volume":"123","author":"Odejide","year":"2017","journal-title":"Cancer"},{"key":"2026082802200682000_16.5.1073.43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/trf.14437","article-title":"Red blood cell transfusion in palliative care: what are we doing and why are we doing it?","volume":"58","author":"Raval","year":"2018","journal-title":"Transfusion"},{"key":"2026082802200682000_16.5.1073.44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/trf.14413","article-title":"Red blood cell transfusion in adult palliative care: a systematic review","volume":"58","author":"Chin\u2010Yee","year":"2018","journal-title":"Transfusion"},{"key":"2026082802200682000_16.5.1073.45","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-012-2077-6"},{"key":"2026082802200682000_16.5.1073.46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2012.03658.x"},{"key":"2026082802200682000_16.5.1073.47","doi-asserted-by":"publisher","DOI":"10.1353\/ken.2007.0021"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2025-005579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:20:59Z","timestamp":1787908859000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2025-005579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,8,28]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/spcare-2025-005579"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2025-005579","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]}}}